Navigation Links
New Stem Cell Growth Strategy Could Yield Better Way to Treat Brain Lesions
Date:5/16/2013

Durham, NC (PRWEB) May 16, 2013

Researchers have found a new way to increase the survival of stem cells injected into the brain. The discovery might one day prove useful in developing new treatments for neurological disorders — especially brain lesions, which among other things can provoke seizures and indicate multiple sclerosis or certain forms of cancer.

The study was performed by Sushma Chaubey, Ph.D., and John H. Wolfe, V.M.D., Ph.D., of the Children's Hospital of Philadelphia’s Research Institute and the University of Pennsylvania School of Veterinary Medicine. It appears in the current issue of STEM CELLS Translational Medicine.

Many medical experts have long believed that neural stem cells (NSCs) have great potential for treating neurological diseases. However, the problem is that just a small number of NSCs can be transplanted into the brain, yielding relatively low levels of new cell growth and, thus, a limited effect. “We wanted to investigate whether using a specific population of neural cells would help increase the number of mature brain cells that the stem cell graft yields,” Dr. Wolfe explained.

The team began by harvesting NSCs from the brains of baby mice and used a process known as fluorescence activated cell sorting to identify cells with markers for CD15, a type of carbohydrate found on a cell’s surface that plays an important role in cell migration, adhesion and in the growth factor signaling involved in cell maintenance and differentiation.

Cells sorting allowed the scientists to achieve a population of cells in which 98 percent were CD15-positive. This process resulted in six times more CD15-positive cells than when cell sorting is not used. These cells were then differentiated in the lab into neurons, astrocytes and oligodendrocytes, which are types of cells found in the central nervous system (the brain and spinal cord). The team next tested both sorted and non-sorted neural cells by injecting them into baby mice. One week later, a time when the brain is still growing, they found that cells from both groups had populated the animals’ brains at a similar level.

“However, in the adult brain the survival of donor cells was significantly higher in the CD15-positive grafts than it was in the unsorted group,” Dr. Wolfe said. In addition, the engrafted stem cells had differentiated into all three types of neural cells with the CD15-positive ones showing a significant tendency to differentiate into oligodendrocytes. This type of cell plays a vital role in protecting neurons.

“This strategy may allow for better delivery of therapeutic cells to the brain,” said Anthony Atala, MD, editor of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine.

“The fact that the CD15-positive cells show a significant increase in oligodendrocytic differentiation suggests that they may be particularly useful for treating diseases involving white matter lesions.”

###

The full article, “Transplantation of CD15-enriched murine neural stem cells increases total engraftment and shifts differentiation towards the oligodendrocyte lineage,” can be accessed at http://www.stemcellstm.com.

About STEM CELLS Translational Medicine:

STEM CELLS TRANSLATIONAL MEDICINE (SCTM), published by AlphaMed Press, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices.

About AlphaMed Press:

Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals: STEM CELLS® (http://www.StemCells.com), celebrating its 31th anniversary in 2012, is the world's first journal devoted to this fast paced field of research. The Oncologist® (http://www.TheOncologist.com), also a monthly peer-reviewed publication, entering its 18th year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally-recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10739497.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Demand for Dental Care Drives Growth in the Dental Orthodontic Supplies Market, According to New Report by Global Industry Analysts, Inc.
2. Global Critical Care Market Will Reach $3.2 Billion in 2019 - Growth from Factor Concentrates, New Indications and Increasing Demand for Albumin in Asia-Pacific
3. Provillus Breakthrough Hair Regrowth Formula Works in a More Gender-Specific Manner
4. Bacteria in Babys Belly May Influence Growth, Study Says
5. Medical Device Companies Eke Out Growth In Tough Market, Finds Latest Kalorama Report
6. New SMB Cloud Market in the APAC Region 2012-2016 - SMB Cloud Industry Share, Size, Trends, Analysis, Growth And Forecast Report To 2016
7. SmartSearch Marketing, a B2B Search Marketing Agency, Adds Content Strategy Manager to Serve Rapid Client Growth
8. Time to tumor growth helps predict survival benefit of Bevacizumab for patients with metastatic colorectal cancer
9. Active Pharmaceutical Ingredients (API) Market in Europe Will Reach $38,255.67 Million By 2017- Pricing and Reimbursement Initiatives Supporting Generic Drug Growth
10. It Works! Global Named Top Company for Growth and Momentum
11. New HGH.com Web Site - Purchasing Human Growth Hormone and Bodybuilding Supplements Just Got Easier
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa ... contributed a medical article to the newly revamped Cosmetic Town journal ... the hair transplant procedure known as Follicular Unit Extraction (FUE). , ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... --  Divoti USA will engrave and process all ... the latest FDA requirements, which stipulates new criteria regarding medical device ... of Medical ID jewelry such as Medical ID Bracelets, can rest ... terms of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
Breaking Medicine Technology: